ANGO
Price
$9.21
Change
+$0.09 (+0.99%)
Updated
Jul 25 closing price
Capitalization
233.95M
68 days until earnings call
AZTA
Price
$34.43
Change
+$0.47 (+1.38%)
Updated
Jul 25 closing price
Capitalization
3.36B
10 days until earnings call
Interact to see
Advertisement

ANGO vs AZTA

Header iconANGO vs AZTA Comparison
Open Charts ANGO vs AZTABanner chart's image
AngioDynamics
Price$9.21
Change+$0.09 (+0.99%)
Volume$411K
Capitalization233.95M
Azenta
Price$34.43
Change+$0.47 (+1.38%)
Volume$437.86K
Capitalization3.36B
ANGO vs AZTA Comparison Chart in %
Loading...
ANGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANGO vs. AZTA commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANGO is a StrongBuy and AZTA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (ANGO: $9.22 vs. AZTA: $34.43)
Brand notoriety: ANGO and AZTA are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ANGO: 56% vs. AZTA: 51%
Market capitalization -- ANGO: $233.95M vs. AZTA: $3.36B
ANGO [@Medical Specialties] is valued at $233.95M. AZTA’s [@Medical Specialties] market capitalization is $3.36B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANGO’s FA Score shows that 0 FA rating(s) are green whileAZTA’s FA Score has 0 green FA rating(s).

  • ANGO’s FA Score: 0 green, 5 red.
  • AZTA’s FA Score: 0 green, 5 red.
According to our system of comparison, both ANGO and AZTA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANGO’s TA Score shows that 4 TA indicator(s) are bullish while AZTA’s TA Score has 4 bullish TA indicator(s).

  • ANGO’s TA Score: 4 bullish, 4 bearish.
  • AZTA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ANGO and AZTA are a good buy in the short-term.

Price Growth

ANGO (@Medical Specialties) experienced а +6.10% price change this week, while AZTA (@Medical Specialties) price change was +10.49% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.05%. For the same industry, the average monthly price growth was +5.16%, and the average quarterly price growth was -1.87%.

Reported Earning Dates

ANGO is expected to report earnings on Oct 02, 2025.

AZTA is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Medical Specialties (+3.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZTA($3.36B) has a higher market cap than ANGO($234M). ANGO YTD gains are higher at: 0.655 vs. AZTA (-31.140). AZTA has higher annual earnings (EBITDA): 57.5M vs. ANGO (-28.49M). AZTA has more cash in the bank: 984M vs. ANGO (60.9M). ANGO has less debt than AZTA: ANGO (4.73M) vs AZTA (66.5M). AZTA has higher revenues than ANGO: AZTA (641M) vs ANGO (330M).
ANGOAZTAANGO / AZTA
Capitalization234M3.36B7%
EBITDA-28.49M57.5M-50%
Gain YTD0.655-31.140-2%
P/E Ratio44.84N/A-
Revenue330M641M51%
Total Cash60.9M984M6%
Total Debt4.73M66.5M7%
FUNDAMENTALS RATINGS
ANGO vs AZTA: Fundamental Ratings
ANGO
AZTA
OUTLOOK RATING
1..100
36
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9490
PRICE GROWTH RATING
1..100
6358
P/E GROWTH RATING
1..100
6058
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANGO's Valuation (71) in the Medical Specialties industry is in the same range as AZTA (75) in the Electronic Production Equipment industry. This means that ANGO’s stock grew similarly to AZTA’s over the last 12 months.

ANGO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as AZTA (100) in the Electronic Production Equipment industry. This means that ANGO’s stock grew similarly to AZTA’s over the last 12 months.

AZTA's SMR Rating (90) in the Electronic Production Equipment industry is in the same range as ANGO (94) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to ANGO’s over the last 12 months.

AZTA's Price Growth Rating (58) in the Electronic Production Equipment industry is in the same range as ANGO (63) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to ANGO’s over the last 12 months.

AZTA's P/E Growth Rating (58) in the Electronic Production Equipment industry is in the same range as ANGO (60) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to ANGO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANGOAZTA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
70%
Declines
ODDS (%)
Bearish Trend 11 days ago
71%
Bearish Trend 12 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
72%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ANGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JISGX21.970.15
+0.69%
JPMorgan Small Cap Growth L
CHTTX21.960.10
+0.46%
AMG River Road Mid Cap Value N
SMEIX18.780.05
+0.27%
Invesco Small Cap Equity R5
RYOIX67.430.06
+0.09%
Rydex Biotechnology Inv
DFIEX18.85-0.02
-0.11%
DFA International Core Equity 2 I

ANGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANGO has been loosely correlated with ICUI. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ANGO jumps, then ICUI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANGO
1D Price
Change %
ANGO100%
+1.21%
ICUI - ANGO
37%
Loosely correlated
+0.55%
BLFS - ANGO
37%
Loosely correlated
+1.44%
MXCT - ANGO
36%
Loosely correlated
-0.88%
HBIO - ANGO
36%
Loosely correlated
-0.93%
AZTA - ANGO
36%
Loosely correlated
+1.38%
More

AZTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with RVTY. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTA
1D Price
Change %
AZTA100%
+1.38%
RVTY - AZTA
65%
Loosely correlated
+1.67%
MTD - AZTA
63%
Loosely correlated
+0.26%
A - AZTA
63%
Loosely correlated
-0.14%
BRKR - AZTA
59%
Loosely correlated
+3.68%
TMO - AZTA
58%
Loosely correlated
+0.69%
More